Trials / Recruiting
RecruitingNCT06755775
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the predictive value of PET imaging targeting granzyme B on the outcome of patients with diffuse large B lymphoma receiving immunotherapy.
Detailed description
The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo 68Ga-grazytracer PET at baseline and after one course of immunotherapy (CAR-T, Glofitamab or iR2 ).
Conditions
Timeline
- Start date
- 2024-07-23
- Primary completion
- 2029-07-23
- Completion
- 2029-07-23
- First posted
- 2025-01-01
- Last updated
- 2025-01-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06755775. Inclusion in this directory is not an endorsement.